A peek inside the FDA’s black box warning labels

Categories: Drug Safety, eDrugSearch.com, FDA, Online Pharmacy Safety, Prescription Drugs | Tags: , , | Posted On:

Today’s Los Angeles Times has a feature analyzing the FDA’s so-called “black box” warning labels — and why some risky drugs receive them while others don’t.

The article specifically poses this question:

Cipro and the similar antibiotics are given the agency’s strictest black box warning label, while epilepsy drugs Lyrica, Depakote and Topamax may have escaped. Why?

eDrugSearch - save on medication costs and get free drug coupons

There’s nothing earthshaking in the piece — the FDA’s decisions are presented as more or less appropriate — but for those interested in how the FDA does its job, it’s a worthwhile procedural. The story is accompanied by a glossary of drug regulation terms.

About Cary Byrd

eDrugSearch founder, Cary Byrd, has been called an “e-health innovator” by MarketIntellNow, interviewed by top pharmaceutical industry journalists, invited to Matthew Holt’s Health 2.0 Conference and a Consumer Report's health summit, and highlighted on numerous health blogs.

eDrugSearch.com - Search. Compare. Save.

0 thoughts on “A peek inside the FDA’s black box warning labels

  • I just found out I was taking a “black Box” antibiotic for laryngitis. There was nothing on the label to warn me, and the doctor didn’t make me aware of what he was perscribing. Why are these practices allowed? Why are these drugs so readily available?

Leave a Reply

Join Our Free Newsletter

Please enter email id

Get a weekly dose of money-saving tips on your medications, drug side effects alerts, drug interaction warnings, free prescription coupons, late-breaking safety information and much, much more!

Share via
Copy link